Berenberg raised the firm’s price target on Amrize (AMRZ) to $70 from $64 and keeps a Buy rating on the shares. The firm upped estimates post the company’s fiscal 2025 results.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMRZ:
- Amrize Expands West Texas Footprint With Acquisition of PB Materials
- Amrize Files 2025 Form 10-K, Highlighting $11.8 Billion in Revenue and North American Scale
- Amrize Boosts Cash Returns as Infrastructure Demand Fuels 2025 Results
- Amrize reports Q4 adjusted EPS 62c, consensus 62c
- Amrize sees FY26 revenue $12.29B-$12.52B, consensus $12.41B